AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21931500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 18310377 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in local hospitals
Number of subjects: 24
Study 18310377 — intervention group
Group type: COMPARATOR
Intervention: Training at the simulation center
Number of subjects: 24
Study 18310377 — intervention group
Group type: COMPARATOR
Intervention: Teamwork theory training
Number of subjects: 24
Study 16781919 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV educational video
Number of subjects: 124
Study 16781919 — intervention group
Group type: COMPARATOR
Intervention: Usual practice with an HIV counselor
Number of subjects: 124
Study 12876632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists for 3 months
Number of subjects: 360
Study 12876632 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonists for 6 months
Number of subjects: 360
Study 12876632 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment durations (3 months and 6 months)
Number of subjects: 360
Study 10947753 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-optical intubation stylet
Number of subjects: 45
Study 10947753 — intervention group
Group type: COMPARATOR
Intervention: Malleable stylet
Number of subjects: 45
Study 9058871 — intervention group
Group type: EXPERIMENTAL
Intervention: RV+ (initial defibrillation current flowing from active can/SVC coil to the RV coil)
Number of subjects: 22
Study 9058871 — intervention group
Group type: COMPARATOR
Intervention: RV- (initial defibrillation current flowing from RV coil to active can/SVC)
Number of subjects: 22
Study 8070990 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal method (routine calming words by dentist) plus BWS
Number of subjects: 30
Study 8070990 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal method plus BWS and alpha relaxation tape
Number of subjects: 30
Study 8070990 — intervention group
Group type: COMPARATOR
Intervention: Verbal method alone
Number of subjects: 30
Study 3330116 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/die slow release nifedipine
Number of subjects: 24
Study 3330116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment response (continued-improvers)
Number of subjects: 465
Study 31647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment response (halted-improvers)
Number of subjects: 465
Study 31647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical remission cut-off score (≤27)
Number of subjects: 465
Study 31647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom reduction score (≥50%)
Number of subjects: 465
Study 30113476 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus postoperative pulmonary rehabilitation program
Number of subjects: 240
Study 30113476 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 240
Study 27410163 — intervention group
Group type: EXPERIMENTAL
Intervention: DN+PENS group
Number of subjects: 62
Study 27410163 — intervention group
Group type: COMPARATOR
Intervention: DN group
Number of subjects: 62
Study 25706266 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed acellular dermal matrix (ADM)
Number of subjects: 30
Study 25706266 — intervention group
Group type: COMPARATOR
Intervention: Control (no biomaterial)
Number of subjects: 30
Study 23931044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (0.5 mmol/kg bolus followed by 0.2 mmol/kg/hour infusion)
Number of subjects: 50
Study 23931044 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride infusion (placebo)
Number of subjects: 50
Study 20494931 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation
Number of subjects: 341
Study 20494931 — intervention group
Group type: COMPARATOR
Intervention: No donor (control group)
Number of subjects: 341
Study 20494931 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation
Number of subjects: 341
Study 20494931 — intervention group
Group type: COMPARATOR
Intervention: High-dose cytarabine (control group)
Number of subjects: 341
Study 20494931 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate/high risk cytogenetic abnormalities
Number of subjects: 341
Study 20494931 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk cytogenetic characteristics
Number of subjects: 341
Study 18468190 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking 2 regular cigarettes
Number of subjects: 42
Study 18468190 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking 2 mentholated cigarettes
Number of subjects: 42
Study 18468190 — intervention group
Group type: COMPARATOR
Intervention: Smoking mentholated cigarettes
Number of subjects: 42
Study 16980158 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 microg kg(‐1) h(‐1), n = 14)
Number of subjects: 28
Study 16980158 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (n = 14)
Number of subjects: 28
Study 12785458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (75 mg or 112.5 mg) plus Acetaminophen (650 mg or 975 mg)
Number of subjects: 1400
Study 12785458 — intervention group
Group type: COMPARATOR
Intervention: Tramadol (75 mg or 112.5 mg)
Number of subjects: 1400
Study 12785458 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen (650 mg or 975 mg)
Number of subjects: 1400
Study 12785458 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 1400
Study 12785458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/Acetaminophen combination
Number of subjects: 1400
Study 10687148 — intervention group
Group type: COMPARATOR
Intervention: Cohort 1: high-dose cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by peripheral blood stem cell infusion and granulocyte colony-stimulating factor at 10 micrograms/kg
Number of subjects: 15
Study 10687148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort 2: CTCb plus rhIL-2 (2 x 10(6) IU/m2/day) for 4 days intravenously via continuous infusion after peripheral blood stem cell infusion
Number of subjects: 15
Study 10687148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cohort 3: CTCb followed by infusion of autologous activated NK cells and rhIL-2 (2 x 10(6) IU/m2/day) for 4 days via continuous intravenous infusion
Number of subjects: 15
Study 8567973 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (0.025 U/kg) infusion over 10 min
Number of subjects: 7
Study 8567973 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (0.025 U/kg) bolus injection
Number of subjects: 7
Study 8567973 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (0.050 U/kg) bolus injection
Number of subjects: 7
Study 8225725 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil solution
Number of subjects: 294
Study 8225725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study 2872054 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (8 mg i.v.)
Number of subjects: 32
Study 2872054 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (0.8 mg i.v.)
Number of subjects: 32
Study 29538506 — intervention group
Group type: EXPERIMENTAL
Intervention: ET+NIV (Exercise Training with Non-Invasive Ventilation)
Number of subjects: 29
Study 29538506 — intervention group
Group type: EXPERIMENTAL
Intervention: ET+Sham (Exercise Training with Placebo NIV)
Number of subjects: 29
Study 29538506 — intervention group
Group type: COMPARATOR
Intervention: Control (Standard Medical Treatment)
Number of subjects: 29
Study 29538506 — intervention group
Group type: EXPERIMENTAL
Intervention: ET+NIV
Number of subjects: 29
Study 29538506 — intervention group
Group type: EXPERIMENTAL
Intervention: ET+Sham
Number of subjects: 29
Study 27116198 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 43
Study 27116198 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 25168488 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable background AD medication
Number of subjects: 4495
Study 25168488 — intervention group
Group type: COMPARATOR
Intervention: Control-arm data (placebo and stable background AD medication)
Number of subjects: 4495
Study 22224560 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual support supplemented by the online parent information and support package
Number of subjects: 80
Study 22224560 — intervention group
Group type: COMPARATOR
Intervention: Usual professional support
Number of subjects: 80
Study 19674789 — intervention group
Group type: EXPERIMENTAL
Intervention: cediranib (RECENTIN™) at doses of ≤30 mg/day
Number of subjects: 35
Study 19674789 — intervention group
Group type: EXPERIMENTAL
Intervention: cediranib (RECENTIN™)
Number of subjects: 35
Study 18279553 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol esters mixed with vegetable oil spreads (2 g/d)
Number of subjects: 200
Study 18279553 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil spread without stanol ester
Number of subjects: 200
Study 15752828 — intervention group
Group type: EXPERIMENTAL
Intervention: Virosomal vaccine (Epaxal)
Number of subjects: 111
Study 15752828 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum-adsorbed vaccine (Havrix 1440)
Number of subjects: 111
Study 15752828 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 111
Study 12883493 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b 1.5 mcg per kg and ribavirin for 48 weeks
Number of subjects: 352
Study 12883493 — intervention group
Group type: COMPARATOR
Intervention: interferon alfa‐2b 3 MU three times a week and ribavirin for 48 weeks
Number of subjects: 352
Study 10583450 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 100 IU daily, increased to 1600 IU daily
Number of subjects: 37
Study 10583450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 8934240 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine monthly changes of percutaneous feeding tubes
Number of subjects: 26
Study 8934240 — intervention group
Group type: COMPARATOR
Intervention: prn changes of percutaneous feeding tubes
Number of subjects: 26
Study 1875728 — intervention group
Group type: EXPERIMENTAL
Intervention: Low therapeutic dosage of methionyl‐human growth hormone (met‐hGH)
Number of subjects: 7
Study 1875728 — intervention group
Group type: EXPERIMENTAL
Intervention: High therapeutic dosage of methionyl‐human growth hormone (met‐hGH)
Number of subjects: 7
Study 1875728 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionyl‐human growth hormone (met‐hGH) supplementation
Number of subjects: 7
Study 1875728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 6662147 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release aminophylline (Phyllocontin)
Number of subjects: 25
Study 6662147 — intervention group
Group type: COMPARATOR
Intervention: Choline Theophyllinate
Number of subjects: 25
Study 30061073 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body resistance exercise training (RET) for 8 weeks, 3 sessions per week at 60-80% maximum force
Number of subjects: 20
Study 30061073 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body resistance exercise training (RET)
Number of subjects: 20
Study 29683408 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (Group A; n = 15)
Number of subjects: 52
Study 29683408 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold bottle (Group B; n = 20)
Number of subjects: 52
Study 29683408 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold bottle + Chewing gum (Group C; n = 17)
Number of subjects: 52
Study 26923616 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate auditory feedback therapy
Number of subjects: 34
Study 26923616 — intervention group
Group type: COMPARATOR
Intervention: Jittered auditory feedback therapy
Number of subjects: 34
Study 25275520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate fruit extract and galangal rhizome (Punalpin) tablets taken daily for three months
Number of subjects: 70
Study 25275520 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets taken daily for three months
Number of subjects: 70
Study 23478695 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 192
Study 20484775 — intervention group
Group type: EXPERIMENTAL
Intervention: VFB(CP0) - Visual feedback of center of pressure displacements in real time
Number of subjects: 56
Study 20484775 — intervention group
Group type: EXPERIMENTAL
Intervention: VFB(CP600) - Visual feedback of center of pressure displacements with a 600-ms delay
Number of subjects: 56
Study 20484775 — intervention group
Group type: EXPERIMENTAL
Intervention: VFB(CP-CG600) - Visual feedback of center of pressure minus center of gravity displacements with a 600-ms delay
Number of subjects: 56
Study 20484775 — intervention group
Group type: COMPARATOR
Intervention: Eyes open - Non-visual feedback condition
Number of subjects: 56
Study 18824758 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery grafting
Number of subjects: 561
Study 18824758 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein grafting
Number of subjects: 561
Study 18824758 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall graft occlusion
Number of subjects: 561
Study 16189518 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 2-week administration followed by 1-week rest for 6 months (arm A)
Number of subjects: 102
Study 16189518 — intervention group
Group type: COMPARATOR
Intervention: S-1 4-week administration followed by 2-week rest for 6 months (arm B)
Number of subjects: 102
Study 12296461 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-coated extracorporeal circuit
Number of subjects: 30
Study 12296461 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated extracorporeal circuit
Number of subjects: 30
Study 12296461 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study 9951491 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.2%
Number of subjects: 135
Study 9951491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 7498641 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 22
Study 7498641 — intervention group
Group type: EXPERIMENTAL
Intervention: Active relaxation
Number of subjects: 22
Study 7498641 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 22
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and levamisole
Number of subjects: 0
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy combination
Number of subjects: 0
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal infusion of cytotoxic drugs
Number of subjects: 0
Study 2100969 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil with leucovorin
Number of subjects: 0
Study 7280636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 150
Study 7280636 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin/Tobramycin
Number of subjects: 150
Study 7280636 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study 27530654 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management and lifestyle program
Number of subjects: 60
Study 27530654 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 28094477 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg/kg loading, 1.5 mg/kg/h infusion)
Number of subjects: 240
Study 28094477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg loading, 0.4 µg/kg/h infusion)
Number of subjects: 240
Study 28094477 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg loading, 1.5 mg/kg/h infusion) and dexmedetomidine (0.5 µg/kg loading, 0.4 µg/kg/h infusion)
Number of subjects: 240
Study 28094477 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 240
Study 25927191 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive, predictors-based intervention delivered via the Internet
Number of subjects: 701
Study 25927191 — intervention group
Group type: EXPERIMENTAL
Intervention: Static informational web site
Number of subjects: 701
Study 25927191 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed sampler of hearing protectors
Number of subjects: 701
Study 25927191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of interventions
Number of subjects: 701
Study 24200100 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Treatment (IT)
Number of subjects: 120
Study 24200100 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Acupuncture (TA)
Number of subjects: 120
Study 24200100 — intervention group
Group type: COMPARATOR
Intervention: Conventional Treatment (CT)
Number of subjects: 120
Study 21905959 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered‐assisted partial turbinectomy
Number of subjects: 0
Study 21905959 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray
Number of subjects: 0
Study 19289630 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg/day
Number of subjects: 486
Study 19289630 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib 500 mg/day
Number of subjects: 486
Study 19289630 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate 40 mg/m2 intravenously weekly
Number of subjects: 486
Study 17878265 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest pain unit care
Number of subjects: 0
Study 15235059 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 186
Study 15235059 — intervention group
Group type: COMPARATOR
Intervention: L‐DOPA
Number of subjects: 186
Study 11230836 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg/day)
Number of subjects: 149
Study 11230836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 9757880 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI candidates
Number of subjects: 186
Study 9757880 — intervention group
Group type: EXPERIMENTAL
Intervention: Azoospermic patients
Number of subjects: 186
Study 9757880 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligospermic patients
Number of subjects: 186
Study 9757880 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 fathers)
Number of subjects: 186
Study 7917794 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination of atenolol (50 mg) and nifedipine (20 mg)
Number of subjects: 102
Study 7917794 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg) alone
Number of subjects: 102
Study 7917794 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 102
Study 3057810 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotropin (recombinant somatropin) with 6-7 injections/week
Number of subjects: 194
Study 3057810 — intervention group
Group type: COMPARATOR
Intervention: Genotropin (recombinant somatropin) with 2-3 injections/week
Number of subjects: 194
Study 3057810 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotropin (recombinant somatropin)
Number of subjects: 194
Study 28782380 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic interval training
Number of subjects: 46
Study 28782380 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 28196011 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (20 min, 1 mA)
Number of subjects: 25
Study 28196011 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (20 min, 1 mA)
Number of subjects: 25
Study 28196011 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 25
Study 25155998 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative interventions
Number of subjects: 496
Study 25155998 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 496
Study 22253268 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 5% in Ringer lactate solution
Number of subjects: 62
Study 22253268 — intervention group
Group type: COMPARATOR
Intervention: Ringer lactate solution (control)
Number of subjects: 62
Study 21897343 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with local anesthetic, lidocaine 0.5%, 10 mL
Number of subjects: 120
Study 21897343 — intervention group
Group type: COMPARATOR
Intervention: Caudal epidural injections with 0.5% lidocaine, 9 mL, mixed with 1 mL of steroid
Number of subjects: 120
Study 18420558 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized responding technique (RRT) treatment group
Number of subjects: 0
Study 18420558 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 0
Study 18420558 — intervention group
Group type: EXPERIMENTAL
Intervention: Refused participation group (prerelease interview)
Number of subjects: 0
Study 17763204 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (average cost of EURO5400)
Number of subjects: 195
Study 17763204 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation
Number of subjects: 195
Study 15157792 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol/150 microg desogestrel
Number of subjects: 53
Study 15157792 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol/75 microg gestodene
Number of subjects: 53
Study 15157792 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol/150 microg desogestrel
Number of subjects: 53
Study 15157792 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol/75 microg gestodene
Number of subjects: 53
Study 11491415 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 82
Study 11491415 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir
Number of subjects: 82
Study 11491415 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir
Number of subjects: 82
Study 11491415 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 82